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A recent study using multilocus sequence typing (MLST) of Burkholderia pseudomallei isolates found a
sequence type (ST60) to be common to both Thailand and Australia, contradicting earlier studies showing
complete distinction between isolates from these regions. The ST60 isolates reportedly from Australia had been
obtained for MLST from United Kingdom and U.S. collections. We have located and characterized the original
Australian isolates; they were collected in 1983, and they are neither ST60 nor B. pseudomallei isolates. The B.
pseudomallei MLST database has been corrected, and there is no ST common to isolates verified as obtained
from Australia or from Thailand.
B. pseudomallei, the environmental bacterium that causes
melioidosis, is widely dispersed throughout Southeast Asia and
northern Australia (8). The true extent of its global distribu-
tion remains very unclear (1), with a recent case cluster of
melioidosis in Brazil (6) confirming the need to consider me-
lioidosis beyond the well-known regions of endemicity.
Multilocus sequence typing (MLST) has been used to clarify
the genetic relationships of B. pseudomallei isolates from dif-
ferent locations (3). MLST initially showed that isolates of B.
pseudomallei from Thailand and those from northern Australia
were distinct (2, 7). However, a recent study comparing a
historical B. pseudomallei collection from Southeast Asia to
that of the MLST database (http://bpseudomallei.mlst.net/)
concluded that Australian isolates may not be distinct from
those of Thailand (4). This conclusion was based on the finding
that MLST ST60 was common to environmental isolates from
both countries. The authors stated that this finding was pro-
foundly significant to melioidosis epidemiology and research,
since the prior finding that Australian B. pseudomallei isolates
were distinct from other isolates sourced elsewhere was no
longer the case.
We have now tracked down the Australian B. pseudomallei
ST60 isolates and show that the results are a case of mistaken
identity. Furthermore, we confirm that to date, all known Aus-
tralian B. pseudomallei STs are indeed distinct from all known
Thai STs. The incorrect attribution of a strain to a specific
geographic location or clinical finding can have major ramifi-
cations, and the scenario we describe illustrates how critical it
is to ensure the accuracy of strain data deposited in publicly
accessible data sets such as the MLST databases.
The five “Australian” ST60 isolates used in the recent study
(4) were all listed in the MLST database as being from envi-
ronmental sources. Three had been obtained for MLST in the
laboratory of B.G.S. from the large B. pseudomallei collection
at the Central Public Health Laboratory, United Kingdom, and
two had been obtained by the Centers for Disease Control
(CDC), United States. We established, through the curator of
the MLST database (D.G.), that the two CDC isolates were
actually the same as two strains from the United Kingdom,
having been part of a collection sent to the CDC from the
United Kingdom. Indeed, it is now recognized that there was
some duplication in the B. pseudomallei MLST database as a
result of the same strains being deposited separately in the
United Kingdom and in the U.S. collections with different
identifiers (data not shown).
Having established that there were only three “Australian”
ST60 strains, we then ascertained their histories. These three
strains had been cultured by A.D.T. in 1983 from soil from a
single property in southeast Queensland, Australia, as part of
an investigation into an outbreak of melioidosis in pigs. These
isolates, D228, D260, and D304, were sent to D.A.D. in the
United Kingdom in 1992. Testing by both A.D.T. and D.A.D.,
including testing by an API 20NE kit (bioMerieux, Paris,
France), the lack of agglutination with B. pseudomallei antisera
and the lack of virulence in guinea pigs had confirmed that
these three were not B. pseudomallei isolates, although they
had not been identified to a species level.
We have now been able to retrieve and reculture two of
these 1983 strains from A.D.T.’s long-term collection; stored
D228 was nonviable. Both D260 and D304 are clearly not B.
pseudomallei strains. They are oxidase-positive gram-negative
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bacilli that cannot be identified to a species level with both an
API 20NE and an API 20E (bioMerieux, Paris, France) kit.
They are agglutination negative with B. pseudomallei antisera
and are negative with the B. pseudomallei-specific type III
secretion system PCR (5). Furthermore, MLST confirmed they
were not B. pseudomallei strains and were completely different
than the ST60 strain. Only four of the seven MLST loci were
able to be sequenced using the normal MLST primers, and the
allelic sequences obtained (which were identical for both D260
and D304) were very divergent from any allele in the MLST
database.
It is now evident that there was a strain identity mixup when
the “Australian” ST60 strains were incorporated into the
United Kingdom collection and were included in the original
MLST study (3). What were thought to be the “Australian”
ST60 strains were presumably ST60 strains from another
source. While the real identities of the strains typed as ST60
remain speculative, it is likely that they were isolates from
Thailand, since Thai isolates make up the vast majority of the
isolates in the United Kingdom collection. ST60 is one of the
more common STs found in Thailand (7).
Two other STs have been attributed to both Australia and
Southeast Asia in the past. There were two “Australian”
ST23 isolates listed in the database that we have found to
also be United Kingdom and CDC duplicates of a single
isolate from the same collection sent by A.D.T. to D.A.D. in
1992. The original isolate, X1003, was isolated by A.D.T. in
1978 from a goat in Townsville, Queensland. We have re-
trieved and recultured this isolate and found it belongs to a
novel ST of B. pseudomallei, ST517, not ST23, confirming
that another isolate substitution error is likely to have oc-
curred. Another “Australian” isolate, typed as ST84, was
cultured from a patient with an uncertain travel history, and
as discussed by McCombie et al., this isolate was likely from
an infection acquired in Southeast Asia (4).
The misidentified isolates have been removed from the
MLST website database. At present, there are 178 STs from
Australia and 224 STs from Thailand represented in the database,
and there is complete separation of Australian and Thai STs
among those isolates whose origins are verifiable from original
sources. B. pseudomallei strain collections in laboratories in re-
gions of nonendemicity often contain a mixture of isolates from
travelers to regions of endemicity who present with melioidosis,
isolates obtained from other collections, and isolates from labo-
ratories in regions of endemicity. Because of the implications of
errors such as those described here, we call for a system of prov-
enance to document the identity, the associated clinical informa-
tion, and the chain of custody of isolates in global databases.
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